2015-01-14

Parkiet Gazeta Gieldy published on 13th January an interview with Piotr Sucharski, NEUCA GROUP's CEO. In the interview the CEO announced the improvement of the results in 2015. Sucharski notices the Group's results will be positively influenced by the benefits of integration with ACP Pharma. Piotr Sucharski confirmed the benefits in 2015-2016 from that take-over will reach PLN 40 million. Still, an accurate prognosis of the net result for the current year will only be presented after the publication of the yearly report.

Sucharski also said, the Group will continue to concentrate on the wholesale distribution of pharmaceuticals when asked about the areas of greater interest. Many efforts will be dedicated to the further development of the private brands segment. Sucharski also stresses the dynamics of new products implementation will not be as great as in the recent years. At the same time more prescribed drugs will be launched, the registration of which is a more time-consuming process. IN the interview with Parkiet Sucharski also announced further development of primary clinics network and entering the new activity areas as telemedicine and clinical trials.

distributed by